Literature DB >> 19243174

Discovery of 4-substituted methoxybenzoyl-aryl-thiazole as novel anticancer agents: synthesis, biological evaluation, and structure-activity relationships.

Yan Lu1, Chien-Ming Li, Zhao Wang, Charles R Ross, Jianjun Chen, James T Dalton, Wei Li, Duane D Miller.   

Abstract

A series of 4-substituted methoxybenzoyl-aryl-thiazoles (SMART) have been discovered and synthesized as a result of structural modifications of the lead compound 2-arylthiazolidine-4-carboxylic acid amides (ATCAA). The antiproliferative activity of the SMART agents against melanoma and prostate cancer cells was improved from muM to low nM range compared with the ATCAA series. The structure-activity relationship was discussed from modifications of "A", "B", and "C" rings and the linker. Preliminary mechanism of action studies indicated that these compounds exert their anticancer activity through inhibition of tubulin polymerization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19243174      PMCID: PMC2760094          DOI: 10.1021/jm801449a

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

1.  SAR studies of 2-arylthiazolidine-4-carboxylic acid amides: a novel class of cytotoxic agents for prostate cancer.

Authors:  Veeresa Gududuru; Eunju Hurh; Joshua Sullivan; James T Dalton; Duane D Miller
Journal:  Bioorg Med Chem Lett       Date:  2005-09-15       Impact factor: 2.823

2.  Synthesis and antiproliferative activity of thiazolidine analogs for melanoma.

Authors:  Wei Li; Yan Lu; Zhao Wang; James T Dalton; Duane D Miller
Journal:  Bioorg Med Chem Lett       Date:  2007-05-23       Impact factor: 2.823

3.  SHELXL: high-resolution refinement.

Authors:  G M Sheldrick; T R Schneider
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

4.  Isoxazoles with antipicornavirus activity.

Authors:  G D Diana; M A McKinlay; C J Brisson; E S Zalay; J V Miralles; U J Salvador
Journal:  J Med Chem       Date:  1985-06       Impact factor: 7.446

5.  Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells.

Authors:  Rishu Guo; Elizabeth A Kasbohm; Puneeta Arora; Christopher J Sample; Babak Baban; Neetu Sud; Perumal Sivashanmugam; Nader H Moniri; Yehia Daaka
Journal:  Endocrinology       Date:  2006-06-29       Impact factor: 4.736

6.  Evaluation of desferrithiocin and its synthetic analogues as orally effective iron chelators.

Authors:  R J Bergeron; J Wiegand; J B Dionis; M Egli-Karmakka; J Frei; A Huxley-Tencer; H H Peter
Journal:  J Med Chem       Date:  1991-07       Impact factor: 7.446

7.  Lysophosphatidic acid stimulates phospholipase D activity and cell proliferation in PC-3 human prostate cancer cells.

Authors:  C Qi; J H Park; T C Gibbs; D W Shirley; C D Bradshaw; K M Ella; K E Meier
Journal:  J Cell Physiol       Date:  1998-02       Impact factor: 6.384

Review 8.  Guanosine phosphate binding protein coupled receptors in prostate cancer: a review.

Authors:  Ganesh V Raj; Liza Barki-Harrington; Pao F Kue; Yehia Daaka
Journal:  J Urol       Date:  2002-03       Impact factor: 7.450

9.  Desazadesmethyldesferrithiocin analogues as orally effective iron chelators.

Authors:  R J Bergeron; J Wiegand; W R Weimar; J R Vinson; J Bussenius; G W Yao; J S McManis
Journal:  J Med Chem       Date:  1999-01-14       Impact factor: 7.446

10.  Addition of colchicine--tubulin complex to microtubule ends: the mechanism of substoichiometric colchicine poisoning.

Authors:  R L Margolis; L Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

View more
  32 in total

1.  Analogue-based approaches in anti-cancer compound modelling: the relevance of QSAR models.

Authors:  Mohammed Hussaini Bohari; Hemant Kumar Srivastava; Garikapati Narahari Sastry
Journal:  Org Med Chem Lett       Date:  2011-07-18

2.  Discovery of 4-Aryl-2-benzoyl-imidazoles as tubulin polymerization inhibitor with potent antiproliferative properties.

Authors:  Min Xiao; Sunjoo Ahn; Jin Wang; Jianjun Chen; Duane D Miller; James T Dalton; Wei Li
Journal:  J Med Chem       Date:  2013-04-09       Impact factor: 7.446

Review 3.  An overview of tubulin inhibitors that interact with the colchicine binding site.

Authors:  Yan Lu; Jianjun Chen; Min Xiao; Wei Li; Duane D Miller
Journal:  Pharm Res       Date:  2012-07-20       Impact factor: 4.200

4.  Discovery of novel 2-aryl-4-benzoyl-imidazoles targeting the colchicines binding site in tubulin as potential anticancer agents.

Authors:  Jianjun Chen; Zhao Wang; Chien-Ming Li; Yan Lu; Pavan K Vaddady; Bernd Meibohm; James T Dalton; Duane D Miller; Wei Li
Journal:  J Med Chem       Date:  2010-10-28       Impact factor: 7.446

5.  Formulation and characterization of polyester/polycarbonate nanoparticles for delivery of a novel microtubule destabilizing agent.

Authors:  Vaibhav Mundra; Yan Lu; Michael Danquah; Wei Li; Duane D Miller; Ram I Mahato
Journal:  Pharm Res       Date:  2012-09-28       Impact factor: 4.200

6.  New substituted 4H-chromenes as anticancer agents.

Authors:  Shivaputra A Patil; Jin Wang; Xiaochen S Li; Jianjun Chen; Terreia S Jones; Amira Hosni-Ahmed; Renukadevi Patil; William L Seibel; Wei Li; Duane D Miller
Journal:  Bioorg Med Chem Lett       Date:  2012-04-24       Impact factor: 2.823

7.  Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma.

Authors:  Vaibhav Mundra; Yang Peng; Virender Kumar; Wei Li; Duane D Miller; Ram I Mahato
Journal:  Drug Deliv Transl Res       Date:  2015-06       Impact factor: 4.617

8.  Polymer conjugate of a microtubule destabilizer inhibits lung metastatic melanoma.

Authors:  Ruinan Yang; Goutam Mondal; Rachel A Ness; Kinsie Arnst; Vaibhav Mundra; Duane D Miller; Wei Li; Ram I Mahato
Journal:  J Control Release       Date:  2017-01-24       Impact factor: 9.776

9.  Pharmacokinetic optimization of 4-substituted methoxybenzoyl-aryl-thiazole and 2-aryl-4-benzoyl-imidazole for improving oral bioavailability.

Authors:  Chien-Ming Li; Jianjun Chen; Yan Lu; Ramesh Narayanan; Deanna N Parke; Wei Li; Sunjoo Ahn; Duane D Miller; James T Dalton
Journal:  Drug Metab Dispos       Date:  2011-07-08       Impact factor: 3.922

10.  Identifying novel molecular structures for advanced melanoma by ligand-based virtual screening.

Authors:  Zhao Wang; Yan Lu; William Seibel; Duane D Miller; Wei Li
Journal:  J Chem Inf Model       Date:  2009-06       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.